ArticleMolecular oncology2022

Evaluation of two new highly multiplexed PCR assays as an alternative to next-generation sequencing for IDH1/2 mutation detection.

Loetitia Favre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.